title: Substrate-dependent effect of 1-34 human parathyroid hormone fragment, dibutyryl cAMP and cAMP on gluconeogenesis in rabbit renal tubules.
abstract: In the presence of 0.5 mM extracellular Ca2+ concentration both 1-34 human parathyroid hormone fragment (0.5 micrograms/ml) as well as 0.1 mM dibutyryl cAMP stimulated gluconeogenesis from lactate in renal tubules isolated from fed rabbits. However, these two compounds did not affect glucose synthesis from pyruvate as substrate. When 2.5 mM Ca2+ was present the stimulatory effect of the hormone fragment on gluconeogenesis from lactate was not detected but dibutyryl cAMP increased markedly the rate of glucose formation from lactate, dihydroxyacetone and glutamate, and inhibited this process from pyruvate and malate. Moreover, dibutyryl cAMP was ineffective in the presence of either 2-oxoglutarate or fructose as substrate. Similar changes in glucose formation were caused by 0.1 mM cAMP. As concluded from the 'crossover' plot the stimulatory effect of dibutyryl cAMP on glucose formation from lactate may result from an acceleration of pyruvate carboxylation due to an increase of intramitochondrial acetyl-CoA, while an inhibition by this compound of gluconeogenesis from pyruvate is likely due to an elevation of mitochondrial NADH/NAD+ ratio, resulting in a decrease of generation of oxaloacetate, the substrate of phosphoenolpyruvate carboxykinase. Dibutyryl cAMP decreased the conversion of fracture 1,6-bisphosphate to fructose 6-phosphate in the presence of both substrates which may be secondary to an inhibition of fructose 1,6-bisphosphatase.
authors.forename: K
authors.initials: K
authors.lastname: Zabłocki
authors.forename: M
authors.initials: M
authors.lastname: Michalik
authors.forename: J
authors.initials: J
authors.lastname: Bryła
mesh_terms: D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology*; D004098:Dihydroxyacetone / Q000378:metabolism; D005632:Fructose / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects*; D005971:Glutamates / Q000378:metabolism; D018698:Glutamic Acid; D007656:Ketoglutaric Acids / Q000378:metabolism; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism*; D007773:Lactates / Q000378:metabolism; D008293:Malates / Q000378:metabolism; D010281:Parathyroid Hormone / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D011773:Pyruvates / Q000378:metabolism; D011817:Rabbits; D013268:Stimulation, Chemical; D019379:Teriparatide / Q000031:analogs & derivatives
chemical_list: D005971:Glutamates; D007656:Ketoglutaric Acids; D007773:Lactates; D008293:Malates; D010281:Parathyroid Hormone; D010446:Peptide Fragments; D011773:Pyruvates; D019379:Teriparatide; D005632:Fructose; D018698:Glutamic Acid; D003994:Bucladesine; C030298:malic acid; D000242:Cyclic AMP; C035748:parathyroid hormone (1-34)amide; D004098:Dihydroxyacetone